InvestorsHub Logo
Followers 4
Posts 929
Boards Moderated 0
Alias Born 08/15/2006

Re: hschlauch post# 42184

Monday, 11/27/2017 8:16:22 PM

Monday, November 27, 2017 8:16:22 PM

Post# of 48316
Thank you, hschlauch.

Looking forward to your take on HALO. While HALO is very intriguing, my untrained view is that pegPh20 is an incremental improvement, while ONCS may well be a quantum leap. Especially if multigene constructs, like your ideas on CD4-positive T regs/FOXP3, leads to complete responses in nearly all melanoma patients.